| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |